Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Other 1Lymphoid 1Breast 1

Conditions

Head and Neck Neoplasms 43Thyroid Neoplasms 18Thyroid Nodule 7Squamous Cell Carcinoma of Head and Neck 7Mouth Neoplasms 7Lung Neoplasms 6Thyroid Diseases 5Neoplasm Metastasis 5Goiter 5Pain, Postoperative 4Nasopharyngeal Neoplasms 4Nasopharyngeal Carcinoma 4Carcinoma, Renal Cell 4Breast Neoplasms 4Parathyroid Neoplasms 3Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Mucositis 3Melanoma 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Xerostomia 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Thyroid Cancer, Papillary 2Stomatitis 2Stomach Neoplasms 2

Interventions

dopexamine 1Norepinephrine 1Epinephrine 1Dobutamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Hypotension × Head & Neck × Clear all
NCT01418118 2011-08-16

Free4Flow

Oxford University Hospitals NHS Trust

Phase 4 Completed
25 enrolled
Head & Neck

Head and Neck Neoplasms, Hypotension, Mouth Neoplasms

NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Mt. Sinai Medical Center, Miami

Phase 4 Completed
452 enrolled
Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡